A Population Pharmacokinetic Analysis of Nelfinavir Mesylate in Human Immunodeficiency Virus-Infected Patients Enrolled in a Phase III Clinical Trial

類似資料

• Population Pharmacokinetics of Lamivudine in Adult Human Immunodeficiency Virus-Infected Patients Enrolled in Two Phase III Clinical Trials
  著者:: Moore, Katy H. P., 等
  出版事項: (1999)
• Lack of Pharmacokinetic Drug Interaction between Tenofovir Disoproxil Fumarate and Nelfinavir Mesylate
  著者:: Boffito, Marta, 等
  出版事項: (2005)
• Pharmacokinetics and Safety of an Antirhinoviral Agent, Ruprintrivir, in Healthy Volunteers
  著者:: Hsyu, Poe-Hirr, 等
  出版事項: (2002)
• Coadministration of Indinavir and Nelfinavir in Human Immunodeficiency Virus Type 1-Infected Adults: Safety, Pharmacokinetics, and Antiretroviral Activity
  著者:: Riddler, Sharon A., 等
  出版事項: (2002)
• Spectrophometric Determination of Nelfinavir Mesylate
  著者:: K. Vanitha Prakash, 等
  出版事項: (2006-01-01)